21:12:03 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandNorge
ListaMERK Equities
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo.

Kalender

2023-04-17 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 Ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 Ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-30 Kvartalsrapport 2020-Q1
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 Ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50
2021-03-01 10:37:57
Reference is made to the stock exchange announcement from SoftOx Solutions AS
(the "Company") on 16 February 2021 regarding the employee offering.

The Board of Directors has resolved to issue a total of 164,348 new shares, each
with a nominal value of NOK 0.02, to employees who had applied for shares. The
shares were issued under a board authorization granted by the Company's general
meeting on 4 January 2021.

The new shares were issued at a subscription price of NOK 55, resulting in gross
proceeds of approx. NOK 9,039,140.
The following primary insiders subscribed and were allocated shares in the
Employee Offering:

- Melvin Teigen (chairman) has subscribed for 10,000 shares at a subscription
price of NOK 55 per offer share in the Employee Offering. Following the
subscription, Teigen holds 16,000 shares in the Company.

- Geir Almås (CEO) has, through his holding company Hermod Farms AS, subscribed
for 36,360 shares at a subscription price of NOK 55 per offer share in the
Employee Offering. Following the subscription, Almås together with his close
associates holds 861 473 shares in the Company.

- Kristine Rød (CFO) has subscribed for 3,637 shares at a subscription price of
NOK 55 per offer share in the Employee Offering. Following the subscription, Rød
holds 3,637 shares in the Company.

- Primary insider Hans Petter Grette has, through his holding company
Renholdsprodukter AS, subscribed for 7,288 shares at a subscription price of NOK
55 per offer share in the Employee Offering. Following the subscription, Grette
together with his close associates holds 90,000 shares in the Company.

- Primary insider Glenn Gundersen has subscribed for 4,550 shares at a
subscription price of NOK 55 per offer share in the Employee Offering. Following
the subscription, Gundersen holds 10,550 shares in the Company.

- Primary insider Elisabeth Ahlmann Ohlsen has subscribed for 200 shares at a
subscription price of NOK 55 per offer share in the Employee Offering. Following
the subscription, Ohlsen holds 200 shares in the Company.

- Primary insider Dag Abrahamsen has, through his holding company Genesis
Holding AS, subscribed for 3,636 shares at a subscription price of NOK 55 per
offer share in the Employee Offering. Following the subscription, Abrahamsen
holds 3,636 shares in the Company.

The shares will be delivered through VPS and will be admitted to trading on
Euronext Growth Oslo following the registration of the shares in the Norwegian
Register of Business Enterprises (Nw: Foretaksregisteret).

This announcement is made under the Norwegian Securities Trading Act Section
4-2.

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, FM of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: +47 977 59 071

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
MedTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com